Antidepressant exposure in pregnancy and risk of autism spectrum disorders.
about
Genetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD)Pharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approachAntidepressant medication during pregnancy and epigenetic changes in umbilical cord blood: a systematic reviewInstrumental variable method for time-to-event data using a pseudo-observation approach.Recent advances in understanding maternal perinatal mood disorders.Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function.In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder.Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence.Association Between Antidepressants Use During Pregnancy and Autistic Spectrum Disorders: A Meta-analysis.Prenatal stress, regardless of concurrent escitalopram treatment, alters behavior and amygdala gene expression of adolescent female rats.Diagnosing and Treating Depression During Pregnancy.Perinatal Generalized Anxiety Disorder: Assessment and Treatment.Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative dataGestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.Selective Serotonin Reuptake Inhibitor Use during Pregnancy and the Risk of Autism Spectrum Disorders: A ReviewDevelopmental changes in serotonin signaling: Implications for early brain function, behavior and adaptationMaternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review.A pharmacological approach to panic disorder during pregnancy.Prenatal Antidepressant Exposure and Childhood Autism Spectrum Disorders: Cause for Concern?Use of psychotropic drugs during pregnancy and breast-feeding.Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta-analysis of cohort studies.Annual Research Review: The role of the environment in the developmental psychopathology of autism spectrum condition.The risks associated with prenatal antidepressant exposure: time for a precision medicine approach.Depression During Pregnancy and Postpartum.Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making.Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence.Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.Use of Antidepressants During Pregnancy?: What to Consider when Weighing Treatment with Antidepressants Against Untreated Depression.Antidepressants during pregnancy and autism in offspring: population based cohort study.Association of Antidepressant Medication Use During Pregnancy With Intellectual Disability in Offspring.Prenatal exposure to antidepressants and risk of epilepsy in childhood.Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort.Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood.Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study.Risk of autism spectrum disorder in offspring following paternal use of selective serotonin reuptake inhibitors before conception: a population-based cohort study.Interactive Effects of Prenatal Antidepressant Exposure and Likely Gene Disrupting Mutations on the Severity of Autism Spectrum Disorder.Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations.Pharmacotherapy of mood disorders and psychosis in pre- and post-natal women.Perinatal SSRI exposure permanently alters cerebral serotonin receptor mRNA in mice but does not impact adult behaviors.Association between maternal antidepressant use during pregnancy and autism spectrum disorder: an updated meta-analysis.
P2860
Q26741618-D8791318-D714-4744-8A88-768A7E81705FQ26774013-1C311DDA-9597-430B-BC8C-FE0212338DCAQ28075452-15EA9676-1024-4F73-A223-F2236FF50467Q31024436-CDE8EA2D-CAFD-40E5-8D08-692BA0F1A8FDQ33806570-AB54CE03-36CF-41BE-95FC-EC9C09839AF6Q33907544-F378FF5A-E2B8-4E14-8450-9F3CEC9A8B58Q34040844-F2DEA6B5-644C-4671-8783-25DED44C3D37Q34047430-A9AB5FE1-725E-463E-ABE2-97306E7932B1Q34075005-98E9207A-7143-4B3B-8071-BB52E0C6E0E1Q35956292-F7EA1344-DB80-40C9-8BB2-804385D7C7DFQ36028297-41001F8D-7C84-44AF-84D7-1C572297FE41Q36108616-035E9421-1AA1-4118-BEBC-72B851E08ACAQ36207250-04A3027A-4BD8-46FE-BDDA-59357B65889AQ36853542-C4256A29-7BEC-4EF3-89B5-61E824CE4011Q37032700-289F3EAD-4B45-40B8-BF2B-AEB719506918Q37643389-AF3AE096-013C-4A3B-A55B-BEC89FAC0F56Q38215072-5ABC6F93-32F5-4986-90BE-4F0483AE5481Q38516009-324C46DB-C7C0-46E9-BC1F-DC6E554F9A31Q38532482-01E79C8B-0626-4274-8195-1C82F00E7389Q38582061-B553540E-194A-4847-9912-5AB3D577ED56Q38653394-4CD4F63F-A4F6-4E2E-8631-1402713E88F2Q38702052-D006F8FB-1091-4F0F-9F83-49AEEEEFB642Q38722632-2E925677-4B6B-4FFD-BFDE-E785A1A9360EQ38734781-7BDEEA13-1B83-4E81-9987-B16EFD93220EQ38811512-1A128F26-A367-4EC7-BA15-2FA869844004Q38823790-A84CD3DB-89A9-4639-8003-B50C0A0D747DQ38832744-BD35C6BD-D1A0-4FB5-BA9F-5B564493572CQ38909371-43409A43-5AF6-4AA3-A84A-79C908092C14Q40116223-1F0EB43F-D6E4-4B31-8229-215556AEBFFCQ40125660-81815B24-4302-4007-A7BE-4A3D5DBCF5D0Q40498883-D617E7CB-8B79-478A-8BC5-1FC0A39EBBBEQ40535696-D7FE4EC0-954C-4516-9740-7D4C775C4DB9Q40583260-2333759E-7458-4A70-94D7-67B367054A6DQ41285360-1EEA90BE-2DD7-448B-9710-C192FA9924BDQ47561017-6B6D4120-DF7B-4CD2-BA9D-67A59BFB073AQ47655108-E0769602-3168-4F73-865E-47E7987D479DQ47733055-137D2886-3A6D-40B3-B48C-254185632BE3Q47743073-34F071FD-EB27-4A83-8ADC-4F03E5969F3DQ47801409-96B3AD3A-35AA-4410-8F00-480F29E3BA8AQ53277650-AE7D9264-45D8-4352-86A9-FA6DA72F7781
P2860
Antidepressant exposure in pregnancy and risk of autism spectrum disorders.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Antidepressant exposure in pregnancy and risk of autism spectrum disorders.
@en
Antidepressant exposure in pregnancy and risk of autism spectrum disorders.
@nl
type
label
Antidepressant exposure in pregnancy and risk of autism spectrum disorders.
@en
Antidepressant exposure in pregnancy and risk of autism spectrum disorders.
@nl
prefLabel
Antidepressant exposure in pregnancy and risk of autism spectrum disorders.
@en
Antidepressant exposure in pregnancy and risk of autism spectrum disorders.
@nl
P2093
P2860
P50
P356
P1476
Antidepressant exposure in pregnancy and risk of autism spectrum disorders.
@en
P2093
Diana Schendel
Merete Juul Sørensen
Mogens Vestergaard
Therese Koops Grønborg
P2860
P304
P356
10.2147/CLEP.S53009
P407
P577
2013-11-15T00:00:00Z